Criterica Intelligence — production models trained on real court records, not synthetic data
Products Liability — MDL No. 2151

Toyota Motor Corp. Unintended Acceleration

U.S. District Court for the Central District of California

The Toyota Unintended Acceleration MDL, centralized in April 2010, brought together two structurally different categories of claims arising from reports that certain Toyota and Lexus vehicles accelerated unexpectedly: nationwide economic-loss claims from owners alleging diminished vehicle value, and personal-injury and wrongful-death claims from crashes attributed to the alleged defect. That dual structure is the single most important thing to understand about this docket's resolution history — the two tracks did not resolve on the same timeline or through the same mechanism.

The economic-loss claims moved through class certification and a large negotiated settlement years into the litigation, substantially closing out that portion of the docket. The personal-injury and wrongful-death track proceeded differently, through individual bellwether-style litigation and case-specific resolution, informed by extensive discovery into electronic throttle-control systems, floor-mat entrapment theories, and competing driver-error explanations that were heavily contested throughout the litigation's active years. With only five actions still pending, what remains today is almost certainly drawn from that harder-to-resolve personal-injury population rather than the already-settled economic-loss class.

What drives resolution risk for any case still open in this docket is the same evidentiary contest that shaped the entire litigation: whether a specific crash is attributable to a vehicle defect or to driver error, evaluated through vehicle-specific data (including event-data-recorder evidence) rather than a generalized causation theory common to a mass drug or device tort. That is a structurally different risk profile from a pharmaceutical or medical-device MDL, where general causation is often the central fight — here, causation is largely incident-specific.

Criterica Intelligence's platform tracks this kind of dual-track docket structure — where an economic-loss claim population and a personal-injury claim population diverge in pace and resolution mechanism — as a distinct structural pattern worth understanding across the active MDL landscape, not just in this one docket.

Frequently Asked Questions
Why did this MDL cover both economic-loss and personal-injury claims?

The JPML centralized both claim types because they arose from the same alleged defect and shared common discovery, even though they ultimately followed different resolution paths — the economic-loss claims through a class settlement, and personal-injury and wrongful-death claims through individual litigation.

What is a bellwether trial and why does it matter here?

A bellwether trial is a representative case tried early to reveal how juries and courts are likely to treat similar claims; in this docket, individual crash cases functioned similarly, testing evidentiary approaches to defect-versus-driver-error causation that informed how later cases were evaluated.

What happens to a case in this MDL if it does not settle?

A case that does not settle proceeds toward individual trial, where causation is decided based on vehicle-specific evidence from that particular crash rather than a docket-wide scientific finding.

Why does this docket look different from a typical drug or device MDL?

Most of the resolution risk here is incident-specific rather than general-causation-driven — each remaining case depends on the facts of a particular crash, not on a single scientific question common to every claim in the docket.

Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.

← All Pending MDLsFunding brief on Criterica Capital →